Current Medicinal Chemistry

Editor-in-Chief

Atta-ur-Rahman, FRS
(32052 citations)
Kings College
University of Cambridge
Cambridge
(UK)

Nobel Laureates on Editorial Board

Prof. John Gurdon
(UK)

Prof. Jean-Marie Lehn
(France)

Prof. Ferid Murad
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor



Meet Our Editorial Board Member free to download

Volume:28   Issue: 5
Pp: 853-853
Peng Zhan
DOI: 10.2174/092986732805210401144635
Published on: 01 April, 2021



Protein Interaction Domains: Structural Features and Drug Discovery Applications (Part 2)

Volume:28   Issue: 5
Pp: 854-892
Marian Vincenzi, Flavia Anna Mercurio and Marilisa Leone*
DOI: 10.2174/0929867327666200114114142
Published on: 01 April, 2021



The Roles of Programmed Cell Death Ligand-1/ Programmed Cell Death-1 (PD-L1/PD-1) in HPV-induced Cervical Cancer and Potential for their Use in Blockade Therapy

Volume:28   Issue: 5
Pp: 893-909
Lifang Zhang, Yu Zhao, Quanmei Tu, Xiangyang Xue, Xueqiong Zhu and Kong-Nan Zhao*
DOI: 10.2174/0929867327666200128105459
Published on: 01 April, 2021



Recent Design and Structure-Activity Relationship Studies on the Modifications of DHFR Inhibitors as Anticancer Agents

Volume:28   Issue: 5
Pp: 910-939
Agnieszka Wróbel and Danuta Drozdowska*
DOI: 10.2174/0929867326666191016151018
Published on: 01 April, 2021



Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds

Volume:28   Issue: 5
Pp: 940-962
Qing-Shan Li*, Bang-Nian Shen, Zhen Zhang, Shuying Luo* and Ban-Feng Ruan*
DOI: 10.2174/0929867327666200306120151
Published on: 01 April, 2021



Small Molecule Inhibitors Targeting Key Proteins in the DNA Damage Response for Cancer Therapy

Volume:28   Issue: 5
Pp: 963-985
Lulu Li, Alagamuthu Karthick Kumar, Zhigang Hu* and Zhigang Guo*
DOI: 10.2174/0929867327666200224102309
Published on: 01 April, 2021



Nanodiagnostic Attainments and Clinical Perspectives on C-Reactive Protein: Cardiovascular Disease Risks Assessment

Volume:28   Issue: 5
Pp: 986-1002
Iswary Letchumanan, M.K. Md Arshad and Subash C.B. Gopinath*
DOI: 10.2174/0929867327666200123092648
Published on: 01 April, 2021



Towards Better Drug Repositioning: Targeted Immunoinflammatory Therapy for Diabetic Nephropathy

Volume:28   Issue: 5
Pp: 1003-1024
Qin Zhang, Ming Yang, Ying Xiao, Yachun Han, Shikun Yang and Lin Sun*
DOI: 10.2174/0929867326666191108160643
Published on: 01 April, 2021



Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab

Volume:28   Issue: 5
Pp: 1025-1041
Qian Xu, Yiming Deng, Jun Xiao, Xiangrui Liu, Min Zhou, Zhong Ren, Juan Peng, Yaling Tang, Zhisheng Jiang, Zhihan Tang* and Lushan Liu*
DOI: 10.2174/0929867327666200505091738
Published on: 01 April, 2021



Recent Research on Flavonoids and their Biomedical Applications

Volume:28   Issue: 5
Pp: 1042-1066
Kangmei Wen, Xiaochuan Fang, Junli Yang, Yongfang Yao, Kutty Selva Nandakumar, Mohamed Labib Salem and Kui Cheng*
DOI: 10.2174/0929867327666200713184138
Published on: 01 April, 2021